NO
NOVIMMUNE SA
Grant-FundedCORDISIntegrating chemical and biological approaches to target NAD production and signaling in cancer
Biotech
NOVIMMUNE SA is a private SME recorded in CORDIS in Switzerland, with participation in 5 EU research and innovation projects. Its recorded projects include “Integrating chemical and biological approaches to target NAD production and signaling in cancer”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€5,213,629
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇨🇭Switzerland
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
NOVIMMUNE SA is a private SME recorded in CORDIS in Switzerland, with participation in 5 EU research and innovation projects. Its recorded projects include “Integrating chemical and biological approaches to target NAD production and signaling in cancer”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
Biotech
Tags:Biotech
Company Info
NOVIMMUNE SA Info
Funding
EU Grants€5,213,629